1-12 Management of Anaphylaxis during Immunotherapy

Friday, 13 December 2013: 11:35 - 11:55
Great Lakes Grand Ballroom West (Westin - Michigan Avenue)

Phil Lieberman, md , University of Tennessee College of Medicine, University of Tennesee College of Medicine, Memphis, TN, TN

Learning Objectives:
Evaluate the inherent risk of administering an allergen to an individual who is sensitized to the substance administered.

Express the effective measures to reduce the risk of these events.

Discuss how to manage and prevent anaphylaxis in patients on immunotherapy.